What is the debt of High Tech Pharm Co this year?
High Tech Pharm Co has a debt level of 243.03 KRW this year.
In 2025, High Tech Pharm Co's total debt was 243.03 KRW, a -98.13% change from the 13,016.94 KRW total debt recorded in the previous year.
High Tech Pharm Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Analyzing High Tech Pharm Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Investors pay close attention to High Tech Pharm Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Shifts in High Tech Pharm Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
High Tech Pharm Co has a debt level of 243.03 KRW this year.
The debt of High Tech Pharm Co has increased by -98.13% compared to the previous year dropped.
High debt can pose a risk for investors of High Tech Pharm Co, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
Low debt means that High Tech Pharm Co has a strong financial position and is able to fulfill its obligations without overburdening its finances.
An increase in debt of High Tech Pharm Co can adversely affect the financial condition of the company and result in a higher burden on its finances.
A reduction in debt of High Tech Pharm Co can strengthen the company's financial position and improve its ability to meet its financial obligations.
Some factors that can influence the debt of High Tech Pharm Co include investments, acquisitions, operating costs, and revenue development.
The debts of High Tech Pharm Co are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
To change the debt, High Tech Pharm Co can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
Over the past 12 months, High Tech Pharm Co paid a dividend of 100 KRW . This corresponds to a dividend yield of about 0.76 %. For the coming 12 months, High Tech Pharm Co is expected to pay a dividend of 100 KRW.
The current dividend yield of High Tech Pharm Co is 0.76 %.
High Tech Pharm Co pays a quarterly dividend. This is distributed in the months of January, January, January, January.
High Tech Pharm Co paid dividends every year for the past 15 years.
For the upcoming 12 months, dividends amounting to 100 KRW are expected. This corresponds to a dividend yield of 0.76 %.
High Tech Pharm Co is assigned to the 'Health' sector.
To receive the latest dividend of High Tech Pharm Co from 4/17/2025 amounting to 100 KRW, you needed to have the stock in your portfolio before the ex-date on 12/27/2024.
The last dividend was paid out on 4/17/2025.
In the year 2024, High Tech Pharm Co distributed 66.667 KRW as dividends.
The dividends of High Tech Pharm Co are distributed in KRW.
Our stock analysis for High Tech Pharm Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of High Tech Pharm Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.